Li Claire Yue, Alexander H Richard
Department of Surgery, New York Presbyterian Hospital, 170 William Street, New York, NY 10038, USA.
Rutgers Cancer Institute of New Jersey, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Surg Oncol Clin N Am. 2018 Jul;27(3):539-549. doi: 10.1016/j.soc.2018.02.010.
Diffuse malignant peritoneal mesothelioma (MPM) is a rare cancer that is ultimately fatal in almost all afflicted individuals. Morbidity and mortality from MPM is due to its propensity to progress locoregionally within the abdominal cavity. Patients with MPM most commonly present with nonspecific abdominal symptoms that usually lead to diagnosis when the condition is relatively advanced. MPM is considered a chemotherapy-resistant malignancy.
弥漫性恶性腹膜间皮瘤(MPM)是一种罕见的癌症,几乎所有患者最终都会死亡。MPM的发病率和死亡率归因于其易于在腹腔内局部进展的倾向。MPM患者最常出现非特异性腹部症状,通常在病情相对晚期时才得以诊断。MPM被认为是一种化疗耐药性恶性肿瘤。